Nano Dimension Ltd - ADR vs uniQure N.V. Ordinary Shares — how do they compare? Nano Dimension Ltd - ADR trades at $1.39 (market cap $299.04M), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: uniQure N.V. Ordinary Shares is far larger — about 4.8× Nano Dimension Ltd - ADR's market cap, and uniQure N.V. Ordinary Shares is more actively traded (3,323,243 versus 1,243,041). Which is the better fit depends on your goals — on Pluang, investors hold Nano Dimension Ltd - ADR for 43 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NNDM | QURE | |
|---|---|---|
Market Cap | $299.04M | $1.45B |
Volume | 1,243,041 | 3,323,243 |
Sector | Technology | Health |
52-Week High | $2.14 | $70.59 |
52-Week Low | $1.21 | $9.03 |
Typical Hold Time | 43 Days | 0 Days |
Enterprise Value | -$105.81M | $707.46M |
Signals from Pluang's Aura AI — not financial advice
Nano Dimension (NNDM) trades at $1.45, down 3.97% with a bearish technical signal. The company reported Q2 2026 revenue of $121M but sustained a net loss of -$163M. Recent strategic moves include appointing a new board member and cost-saving initiatives expected to reduce cash burn by $25M annually. The stock shows oversold conditions with RSI at 12.66, while moving averages indicate bearish pressure.
Despite cost-cutting efforts, NNDM faces significant fundamental challenges with negative profitability margins and cash flow concerns. The company's high cash position provides some buffer, but persistent losses and leadership transitions create uncertainty. Investors should monitor execution of turnaround strategies and path to profitability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →